Glitazones are associated with reduced risk of Parkinson’s disease

Click for article

Click for article

Patients who take the antidiabetes drugs rosiglitazone or pioglitazone have a lower risk of developing Parkinson’s disease than patients taking other drugs for diabetes, a study published in PLoS Medicine indicates.